CARIBOU BIOSCIENCES INC (CRBU) Stock Analyst Ratings
USA - NASDAQ:CRBU - US1420381089 - Common Stock
2.37 USD
-0.1 (-4.05%)
2.34 USD
-0.03 (-1.27%)
ChartMill assigns a Buy % Consensus number of 84% to CRBU. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.03. This target is 281.19% above the current price.
CRBU was analyzed by 14 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CRBU.
In the previous month the buy percentage consensus was at a similar level.
CRBU was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-07 | B of A Securities | Maintains | Buy -> Buy |
| 2024-11-26 | Citigroup | Maintains | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-07-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-16 | Truist Securities | Maintains | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-12 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-11-08 | Cantor Fitzgerald | Initiate | Neutral |
| 2023-07-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-14 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-07-11 | Truist Securities | Initiate | Buy |
| 2023-05-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-14 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-10 | Oppenheimer | Maintains | Outperform |
| 2023-03-10 | RBC Capital | Reiterate | Outperform |
| 2022-08-29 | Citigroup | Maintains | Buy |
| 2022-08-18 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-10 | RBC Capital | Maintains | Outperform |
| 2022-05-13 | Citigroup | Maintains | Buy |
| 2022-05-12 | SVB Leerink | Maintains | Outperform |
| 2022-05-10 | SVB Leerink | Maintains | Outperform |
| 2022-02-18 | RBC Capital | Initiate | Outperform |
| 2022-02-14 | Brookline Capital | Initiate | Buy |
CARIBOU BIOSCIENCES INC / CRBU FAQ
What do analysts expect the price target to be for CARIBOU BIOSCIENCES INC (CRBU)?
14 analysts have analysed CRBU and the average price target is 9.03 USD. This implies a price increase of 281.19% is expected in the next year compared to the current price of 2.37.
How do analysts rate CARIBOU BIOSCIENCES INC (CRBU)?
The consensus rating for CARIBOU BIOSCIENCES INC (CRBU) is 84.2857 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for CRBU stock?
The number of analysts covering CARIBOU BIOSCIENCES INC (CRBU) is 14.